Price T Rowe Associates Inc Spring Works Therapeutics, Inc. Transaction History
Price T Rowe Associates Inc
- $869 Billion
- Q3 2024
A detailed history of Price T Rowe Associates Inc transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 3,516,418 shares of SWTX stock, worth $132 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,516,418
Previous 3,602,234
2.38%
Holding current value
$132 Million
Previous $136 Million
16.97%
% of portfolio
0.01%
Previous 0.02%
Shares
16 transactions
Others Institutions Holding SWTX
# of Institutions
238Shares Held
69.8MCall Options Held
144KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA6.71MShares$251 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$210 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.84MShares$144 Million4.54% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$128 Million5.82% of portfolio
-
State Street Corp Boston, MA3.09MShares$116 Million0.0% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.34B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...